Concepedia

M. Li

ML

4

Publications

220

Citations

4

H-Index

2005

Active since

Affiliations

Pfizer (United States)(Current)

The University of Texas MD Anderson Cancer Center

M. Li is an author at Pfizer (United States) specializing in cell biology, osteoporosis, and medicine.

ORCID

Top concepts

Publications per year

2005–2024

4

Publications

4

Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice

M. Li, David R. Healy, Y. Li et al. · Bone · 2005 · 84 citations

, , +9

Surface-specific effects of a PPARγ agonist, darglitazone, on bone in mice

M. Li, Lydia C. Pan, Hollis A. Simmons et al. · Bone · 2006 · 55 citations

, , +10

Inhibition of lysine acetyltransferase KAT6 in ER+HER2− metastatic breast cancer: a phase 1 trial

Toru Mukohara, Yeon Hee Park, David Sommerhalder et al. · Nature Medicine · 2024 · 44 citations · Full text

A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations

Jordi Rodón, Estelamari Rodríguez, Michael L. Maitland et al. · ESMO Open · 2024 · 37 citations · Full text

Rows per page

1–4 of 4